title: Community associated methicillin resistant staphylococcus aureus (CA-MRSA) infective endocarditis in Italy.
authors.forename: M
authors.initials: M
authors.lastname: Bassetti
authors.forename: E
authors.initials: E
authors.lastname: Nicco
authors.forename: M
authors.initials: M
authors.lastname: Malgorzata
authors.forename: C
authors.initials: C
authors.lastname: Viscoli
authors.forename: A
authors.initials: A
authors.lastname: Valbusa
authors.forename: D
authors.initials: D
authors.lastname: Bongiorno
authors.forename: F
authors.initials: F
authors.lastname: Campanile
authors.forename: S
authors.initials: S
authors.lastname: Stefani
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001826:Body Fluids / Q000382:microbiology; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D017576:Daptomycin / Q000008:administration & dosage; D017548:Echocardiography, Transesophageal; D004696:Endocarditis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006801:Humans; D007558:Italy; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification*; D008875:Middle Aged; D020519:Pericardiocentesis; D012293:Rifampin / Q000008:administration & dosage; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin; D012293:Rifampin